$VRAX· SEC filing ·

VRAX Announces $6.4M Cash Position, $25B PAIS Market, ViraxImmune™ LDT Pathway, ISO 13485 Certified, Debt-Free, $2.6M Valuation Gap

Virax Biolabs Group Limited Ordinary Shares · Now $0.18

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS